BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 1537.10 | 1539.00 | 20 |
3 | 1537.05 | 1539.30 | 1 |
1 | 1537.00 | 1539.35 | 22 |
4 | 1536.80 | 1539.50 | 3 |
13 | 1536.75 | 1539.55 | 19 |
29444 | Total | Total | 35109 |
As on 30 Jan, 2023 | 03:03
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 1537.10 | 1539.00 | 20 |
3 | 1537.05 | 1539.30 | 1 |
1 | 1537.00 | 1539.35 | 22 |
4 | 1536.80 | 1539.50 | 3 |
13 | 1536.75 | 1539.55 | 19 |
29444 | Total | Total | 35109 |
As on --
(OI , PRICE )
As on --
Stock with good financial performance alongside good to expensive valuation
Open | 1,542.85 |
Previous Close | 1,537.40 |
Volume | 313,153.00 |
Value (Lacs) | 4,854.03 |
VWAP | 1,549.12 |
Beta |
High | 1,562.40 |
Low | 1,532.55 |
UC Limit | 1,691.10 |
LC Limit | 1,383.70 |
52 Week High | 1,750.00 |
52 Week Low | 1,242.08 |
TTM EPS See historical trend | 24.55 (-65.92% YoY) |
TTM PE See historical trend | 63.14 (High PE) |
P/B See historical trend | 8.82 (High P/B) |
Face Value | 5.00 |
Mkt Cap (Rs. Cr.) | 52,461 |
Dividend Yield | 3.10 |
20D Avg Volume | 156,309 |
20D Avg Delivery(%) | 61.66 |
Sector PE | 27.44 |
Book Value Per Share | 175.88 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Hold Torrent Pharmaceuticals; target of Rs 1720: ICICI Direct Jan 29 2023 07:01 PM
Torrent Pharma Consolidated December 2022 Net Sales at Rs 2,491.00 crore, up 18.17% Y-o-Y Jan 25 2023 11:01 PM
Torrent Pharma Standalone December 2022 Net Sales at Rs 1,857.00 crore, up 16.94% Y-o-Y Jan 25 2023 10:01 PM
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang Jan 17 2023 02:01 PM
Qty 159853 | Price 1669.05 | % Traded 0.05 |
Qty 159853 | Price 1669.05 | % Traded 0.05 |
Qty 159853 | Price 1694.3 | % Traded 0.05 |
Qty 159853 | Price 1694.3 | % Traded 0.05 |
Qty 86000 | Price 1567.3 | % Traded 0.03 |
Qty 86000 | Price 1567.3 | % Traded 0.03 |
Qty 135148 | Price 1595.05 | % Traded 0.04 |
Qty 135148 | Price 1595.05 | % Traded 0.04 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 2040623 | Price 2367.2 | % Traded 0.60 |
Qty 1149669 | Price 2365.32 | % Traded 0.34 |
Qty 901207 | Price 1475.08 | % Traded 0.27 |
Qty 8858864 | Price 1440 | % Traded 2.62 |
Qty 8858864 | Price 1440 | % Traded 2.62 |
Qty 19704108 | Price 1401 | % Traded 5.82 |
Qty 5885276 | Price 1401 | % Traded 1.74 |
Qty 6283860 | Price 1401 | % Traded 1.86 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 3600 | Price 2793.9 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 6875 | Price 2899.91 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 1050 | Price 2803.83 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 1820 | Price 2750.01 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 730 | Price 2736.97 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 200 | Price 2778 | % Traded 0.00 | Post Tnx Hold. 0% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 6283860 | Price 0 | % Traded 3.71 | Post Tnx Hold. 0% |
Qty 6120168 | Price 0 | % Traded 6.62 | Post Tnx Hold. 0% |
Qty 5885276 | Price 0 | % Traded 3.48 | Post Tnx Hold. 0% |
Qty 25589384 | Price 0 | % Traded 15.12 | Post Tnx Hold. 0% |
Qty 25589384 | Price 0 | % Traded 15.12 | Post Tnx Hold. 66.01% |
Qty 8858864 | Price 0 | % Traded 5.24 | Post Tnx Hold. 0% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Torrent Pharma | 1,540.20 | 0.18 | 52,127.37 | 62.74 | 8.76 | 13.05 | 15.91 | 777 | 8,508 | 0.67 |
Sun Pharma | 1,047.95 | 0.44 | 251,438.31 | 61.25 | 4.92 | 6.81 | 26.66 | 3,405 | 38,654 | 0.02 |
Divis Labs | 3,366.00 | -0.63 | 89,356.72 | 29.86 | 7.62 | 25.24 | -14.58 | 2,960 | 8,959 | 0.00 |
Cipla | 1,037.70 | -0.91 | 83,757.33 | 31.74 | 3.97 | 12.07 | 11.31 | 2,559 | 21,763 | 0.04 |
Dr Reddys Labs | 4,313.20 | -0.02 | 71,824.98 | 19.71 | 3.74 | 11.35 | 2.24 | 2,112 | 21,545 | 0.16 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>